title: FGF-21 alleviates diabetes-associated vascular complications: Inhibiting NF-κB/NLRP3 inflammasome-mediated inflammation?
authors.affiliation: Department of Clinical Laboratory, Affiliated Nanhua Hospital, University of South China, No. 336 Dongfeng South Road, Hengyang 421001, Hunan, China. Electronic address: mihualiu@163.com.
authors.forename: Mi-Hua
authors.initials: MH
authors.lastname: Liu
mesh_terms: D000818:Animals; D003925:Diabetic Angiopathies / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control*; D005346:Fibroblast Growth Factors / Q000494:pharmacology*; D006801:Humans; D058847:Inflammasomes / Q000276:immunology*; D007249:Inflammation / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism*
chemical_list: D058847:Inflammasomes; D016328:NF-kappa B; C414620:fibroblast growth factor 21; D005346:Fibroblast Growth Factors
keywords: FGF-21; Inflammation; NLRP3 inflammasome